Anti-SARS-CoV-2 QuantiVac ELISA (IgG)
The Anti-SARS-CoV-2 QuantiVac ELISA (IgG) provides quantitative measurement of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2. The antibody concentration is determined in standardised binding antibody units (BAU/ml) according to international reference material. The test supports assessment of the level of immune reaction following SARS-CoV-2 infection or vaccination with spike protein-based vaccines.
Receive your quote directly from the manufacturer.
Easy to use, reliable and excellent results.
Immunology anti Sars-Cov-2 IgG anti S1 detection and quantification
It allows a good evaluation of the humoral immune response in seroprevalence studies and those related to the development of vaccines based on spike proteins. The assay also shows an excellent correlation with the current WHO Standard.
Review Date: 7 Apr 2021 | EUROIMMUN
- Quantitative detection of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2 using a 6-point calibration curve
- Excellent correlation with the WHO International Standard (NIBSC code: 20/136) – enables issuing of results in standardised units
- Very good agreement of results in comparison with different neutralisation tests
- Validated for serum, plasma and dried capillary blood as sample material
- Fully automatable
- CE marked
